Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial-Based Cost Data. (2017)
Attributed to:
Epidemiological contribution to primary and secondary prevention of diabetes and obesity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jval.2017.05.018
PubMed Identifier: 29241888
Publication URI: http://europepmc.org/abstract/MED/29241888
Type: Journal Article/Review
Volume: 20
Parent Publication: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Issue: 10
ISSN: 1098-3015